Legend Biotech (LEGN) Interest & Investment Income (2020 - 2025)
Legend Biotech (LEGN) reported Interest & Investment Income of $40.1 million for Q4 2025, down 34.48% on a YoY basis from $61.2 million in Q4 2024, and up 24.73% quarter-over-quarter from $32.2 million in Q3 2025.
Legend Biotech (LEGN) Interest & Investment Income (2020 - 2025) Analysis & Trends
Legend Biotech has reported Interest & Investment Income for 6 years, with the latest figure at $40.1 million in Q4 2025.
- For the quarter ending Q4 2025, Interest & Investment Income fell 34.48% year-over-year to $40.1 million; the trailing twelve-month figure through Dec 2025 stood at $40.1 million (down 34.48% YoY), and the FY2025 full-year result was $40.1 million, down 34.48% from the prior year.
- Interest & Investment Income for Q4 2025 stood at $40.1 million, up from $32.2 million in the prior quarter.
- The five-year high for Interest & Investment Income was $61.2 million in Q4 2024, with the low at -$37.2 million in Q3 2023.
- Historically, Interest & Investment Income has averaged $6.9 million across 5 years, with a median of -$548000.0 in 2021.
- Annual changes were most pronounced in 2023 — Interest & Investment Income sank 1374.89% — and 2024, when it soared 264.77%.
- Legend Biotech's Interest & Investment Income stood at -$971000.0 in 2021, then slumped by 742.64% to -$8.2 million in 2022, then slumped by 354.47% to -$37.2 million in 2023, then soared by 264.58% to $61.2 million in 2024, then plunged by 34.48% to $40.1 million in 2025.
- The last three Interest & Investment Income figures came in at $40.1 million (Q4 2025), $32.2 million (Q3 2025), and $22.5 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 40.10 Mn |
| Sep 30, 2025 | 32.15 Mn |
| Jun 30, 2025 | 22.49 Mn |
| Mar 31, 2025 | -12.06 Mn |
| Dec 31, 2024 | 61.20 Mn |
| Sep 30, 2024 | 47.55 Mn |
| Jun 30, 2024 | 30.92 Mn |
| Mar 31, 2024 | -13.87 Mn |
| Sep 30, 2023 | -37.19 Mn |
| Jun 30, 2023 | -18.77 Mn |
| Mar 31, 2023 | -6.76 Mn |
| Dec 31, 2022 | -8.18 Mn |
| Sep 30, 2022 | -3.29 Mn |
| Jun 30, 2022 | -1.79 Mn |
| Mar 31, 2022 | -458,000.00 |
| Dec 31, 2021 | -971,000.00 |
| Sep 30, 2021 | -548,000.00 |
| Jun 30, 2021 | -227,000.00 |
| Mar 31, 2021 | -100,000.00 |
| Dec 31, 2020 | -2.93 Mn |